EEF1A2 expression is reported to be associated with good prognosis in breast cancer [30] and non-small cell lung cancer [31] On the contrary, it predicts worse survival in pancreatic [32], ovarian [33] and gastric cancers [34]. Here, EEF1A2 is linked to breast carcinoma.